BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22671975)

  • 21. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma.
    Bravo-Calderón DM; Oliveira DT; Marana AN; Nonogaki S; Carvalho AL; Kowalski LP
    Cancer Biomark; 2011-2012; 10(1):51-9. PubMed ID: 22297552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hamster model of sequential oral oncogenesis.
    Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
    Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
    Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
    PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
    Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
    Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
    Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P
    Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laminin-5 gamma 2: a marker to identify oral mucosal lesions at risk for tumor development?
    Nordemar S; Högmo A; Lindholm J; Auer G; Munck-Wikland E
    Anticancer Res; 2003; 23(6D):4985-9. PubMed ID: 14981956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
    AbdulMajeed AA; Dalley AJ; Farah CS
    Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortactin and focal adhesion kinase as predictors of cancer risk in patients with premalignant oral epithelial lesions.
    de Vicente JC; Rodrigo JP; Rodriguez-Santamarta T; Lequerica-Fernández P; Allonca E; García-Pedrero JM
    Oral Oncol; 2012 Jul; 48(7):641-6. PubMed ID: 22377015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stromelysin-3 expression is an early event in human oral tumorigenesis.
    Soni S; Mathur M; Shukla NK; Deo SV; Ralhan R
    Int J Cancer; 2003 Nov; 107(2):309-16. PubMed ID: 12949813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical expression of p16(INK4A) protein as a helpful marker of a subset of potentially malignant oral epithelial lesions: study on a series with long-term follow-up.
    Montebugnoli L; Cervellati F; Cocchi R; Farnedi A; Pennesi MG; Flamminio F; Foschini MP
    Histopathology; 2010 Oct; 57(4):528-34. PubMed ID: 20955378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
    Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
    Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
    Mishra R; Das BR
    Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC).
    Chen JY; Chang YL; Yu YC; Chao CC; Kao HW; Wu CT; Lin WC; Ko JY; Jou YS
    Carcinogenesis; 2004 Feb; 25(2):269-76. PubMed ID: 14604896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of pituitary tumor transforming gene expression with early oral tumorigenesis and malignant progression of precancerous lesions.
    Liao LJ; Hsu YH; Yu CH; Chiang CP; Jhan JR; Chang LC; Lin JJ; Lou PJ
    Head Neck; 2011 May; 33(5):719-26. PubMed ID: 21069851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metallothionein and p-Akt proteins in oral dysplasia and in oral squamous cell carcinoma: an immunohistochemical study.
    Pontes HA; de Aquino Xavier FC; da Silva TS; Fonseca FP; Paiva HB; Pontes FS; dos Santos Pinto D
    J Oral Pathol Med; 2009 Sep; 38(8):644-50. PubMed ID: 19453843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
    Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
    Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear factor κB and cyclooxygenase-2 immunoexpression in oral dysplasia and oral squamous cell carcinoma.
    Pontes HA; Pontes FS; Fonseca FP; de Carvalho PL; Pereira EM; de Abreu MC; de Freitas Silva BS; dos Santos Pinto D
    Ann Diagn Pathol; 2013 Feb; 17(1):45-50. PubMed ID: 22818026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy.
    Dalley AJ; AbdulMajeed AA; Upton Z; Farah CS
    J Oral Pathol Med; 2013 Jan; 42(1):37-46. PubMed ID: 22643025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta- and gamma-catenin expression in oral dysplasia.
    Lo Muzio L; Lo Russo L; Falaschini S; Ciavarella D; Pentenero M; Arduino P; Favia G; Maiorano E; Rubini C; Pieramici T; Gandolfo S
    Oral Oncol; 2009 Jun; 45(6):501-4. PubMed ID: 18715817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.